Molecular genetic analysis of HLA-DRB, -DQA, and -DQB polymorphisms in Hungarians and distribution of the DRB1*03 allele in adults and newborns

Experimental and Clinical Immunogenetics

Volumn 13, Issue 3-4, 1996, Pages 204-209

  Varga, Éva ^a   Endreffy, Emõke ^b   Samu, Gabriella ^a   Szekeres, Éva ^a   Tóth, Ferenc ^c   Bede, Olga ^b   Petri, Ildikó B ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Paediatric Department   (Hungary)

^c Oto Rhino Laryngology Department   (Hungary)

Author keywords

HLA DQA alleles; HLA DQB alleles; HLA DRB alleles; HLA DRB1*03 allele; Hungarian population; Polymerase chain reaction; Restriction fragment length polymorphism; Sequence specific primers

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUNGARY; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MOLECULAR GENETICS; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALLELES; GENE FREQUENCY; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; HUNGARY; INFANT, NEWBORN; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0030431438     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bodmer JG, Marsh SGE, Albert ED: Nomenclature for factors of the HLA system. Hum Immunol 1995; 43:149-164.
2. Olerup O, Zetterquist H: HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens 1992;39:225-235.
3. Cros P, Allibert P, Mandrand B, Tiercy JM, Mach B: Oligonucleotide genotyping of HLA polymorphism on microtitre plates. Lancet 1992, 340:870-873.
4. Ota M, Seki T, Nomura N: Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Tissue Antigens 1991;38:60-71.
5. Mercier B, Ferec C, Dufosse F, Huart J-J: Improvement in HLA-DQB typing by PCR-RFLP: Introduction of a constant restriction site in one of the primers for digestion control. Tissue Antigens 1992;40: 86-89.
6. Grubic Z, Zunec R, Naipal A, Kastelan A, Giphart MJ: Molecular analysis of HLA class II polymorphism in Croatians. Tissue Antigens 1995;46:293-298.
7. Boki KA, Panayi GS, Vaughan RW: HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. Arthritis Rheum 19092;35:749-755.
8. Nielsen LS, Eiberg H, Fenger K, Mohr J: An MHC (HLA-A, -B, -C2, -BF, HLA-DR, GLO1) haplotype study of 497 Danish normal families with 1970 children including 97 twin pairs. Tissue Antigens 1990;36: 141-148.
9. Kocova M, Blagoevska M, Bogoevski M, Konstantinova M, Dorman J, Trucco M: HLA class II molecular typing in an European Slavic population with a low incidence of insulin-dependent diabetes mellitus. Tissue Antigens 1995,45:216-219.
10. Djoulan S, Sanchez-Mazas A, Khalil I: HLA-DRB1, DQA1 and DQB1 DNA polymorphisms in healthy Algerians and genetic relationships with other populations. Tissue Antigens 1994;43:102-109.
11. Reed E, Ho E, Lupu F, McManus P: Polymorphism of HLA in Romanian population. Tissue Antigens 1992;39:8-19.
12. Ivanova R, Naoumova E, Lepage V, Djoulah S, Yordanov Y, Loste MN, Charon D: HLA-DRB1, DQA1, DQB1 DNA polymorphism in the Bulgarian population. Tissue Antigens 1996;47:122-126
13. Martinez-Laso J, Gazit E, Gomez-Casado E, Morales P, Martinez-Quiles N, Alvarez M, Martin-Villa JM, Fernandez V, Arnaiz-Villena A: HLA DR and DQ polymorphism in Ashkenazi and non-Ashkenazi Jews: Comparison with other Mediterraneans. Tissue Antigens 1996;47:63-71.
14. Menevse S, Ulkuer U: The distribution of the HLA-DQA alleles and genotypes in the Turkish population as determined by use of DNA amplification and allele-specific oligonucleotides. Sci Justice 1995;35: 259-262.
15. Huguet E, Gené M, Corbella J, Moreno P: Distribution of the HLA-DQA alleles and genotypes in a sample of a population from Barcelona (Spain). Hum Hered 1993;43:326-328.
16. Modica MA, Colucci AT, Candore G, Caruso C: The HLA-B8, DR3 haplotype and immune response in healthy subjects. Immunol Infect Dis 1993;3:119.
17. Amer A, Singh G, Darke C, Dolby AE: Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HAL-B8/DR3. Tissue Antigens 1986;28:193.
18. Candore G, Gigna D, Gervasi F, Colucci AT, Modica MA, Caruso C: In vitro cytokine production by HLA-B8, DR3-positive subjects. Autoimmunity 1994;18:121.
19. Hashimoto S, Michalsky JP, Berman MA, McCombs C: Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: Role of interleukin-1. Clin Exp Immunol 1990;79:227-232.
20. Lio D, D'Anna C, Gervasi F: In vitro impairment of interleukin-5 production in HLA-B8, DR3-positive individuals. Hum Immunol 1995;41:170-174.
21. Gupta S: Autologous mixed lymphocyte reaction in health and disease states in man. Vox Sang 1983; 44:265.
22. Modica MA, Freddi S, Caruso C: Blood IgA, IgM and IgE levels are influenced by sex and HLA phenotype. Exp Clin Immunogenet 1989; 6.251.
23. Hammarstrom L, Axelsson U, Bjorkander J, Hanson A, Moller E, Smith CIE: HLA antigens in selective IgA deficiency: Distribution in healthy donors and patients with recurrent respiratory tract infections. Tissue Antigens 1984;24:35.
24. Caruso C, Candore G, Colucci AT, Cigna D, Modica MA, Tantillo G, Salerno A: Natural killer and lymphokine-activated killer activity in HLA-B8, DR3-positive subjects. Hum Immunol 1993;38:226.
25. Modica MA, Zambito AM, Candore G, Caruso C: Markers of T lymphocyte activation in HLA-B8, DR3 positive individuals. Immunology 1990;181:257-266.
26. Alper CA: The human immune response to hepatits B surface antigen. Exp Clin Immunogenet 1995;12: 171-181.
27. Varla-Leftheroti M, Papanicolau M: HLA associated non-responsiveness to hepatitis B vaccine. Tissue Antigens 1990;35:60-63.
28. Steel C, Beatson D, Cuthbert RJG: HLA haplotype A1B8DR3 as a risk factor for HIV-related disease. Lancet 1990;335:927-930.
29. Posch PE, Araujo HA, Creswell K, Fraud C, Johnson AH, Hurley CK: Microvariation creates significant functional differences in the DR3 molecules. Hum Immunol 1995;42: 61-71.
30. Posch PE, Hurley CK, Geluk A, Ottenhoff THM: The impact of DR3 microvariation on peptide binding: The combinations of specific DRB residues critical to binding differ for different peptides. Hum Immunol 1996;49:96-105.
31. Van Rood JJ, Van Hooff JP, Keuning JJ: Disease predisposition, immune responsiveness and the fine structure of the HLA-A supergene. Transplant Rev 1975;22:75.